Throughout the first half of 2020, much of the world has grappled with the reality of the coronavirus (COVID-19) pandemic, as the outbreak spread rapidly across entire countries and shut down large segments of the global...more
7/7/2020
/ ACPERA ,
Antitrust Provisions ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
DPA ,
Pharmaceutical Industry ,
Price-Fixing ,
Remote Working ,
UK ,
UK Competition and Markets Authority (CMA) ,
Whistleblower Protection Policies